Diazocine derivatives and their use as tryptase inhibitors

Details Diazocine derivatives and their use as tryptase inhibitors Diazocine derivatives and their use as tryptase inhibitors

2005-08-02

2005-08-02

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C540S460000

Reexamination Certificate

active

06924305

ABSTRACT:
Compounds of the formula I, in which B1, B2, R1, R2, R6, R7, K1 and K2 are as defined in the description are novel effective tryp-tase inhibitors.

REFERENCES:
patent: 6489327 (2002-12-01), Bär et al.
patent: WO 95/32945 (1995-12-01), None
patent: WO 96/09297 (1996-03-01), None
patent: WO 98/04537 (1998-02-01), None
patent: WO 99/12918 (1999-03-01), None
patent: WO 99/24395 (1999-05-01), None
patent: WO 99/24407 (1999-05-01), None
patent: WO 99/40073 (1999-08-01), None
patent: WO 99/40083 (1999-08-01), None
patent: WO 00/14097 (2000-03-01), None
patent: WO 01/10845 (2001-02-01), None
patent: WO 01/10848 (2001-02-01), None
patent: WO 01/19809 (2001-03-01), None
patent: WO 01/46128 (2001-06-01), None
patent: WO 01/46168 (2001-06-01), None

Affiliated with

Also associated with

Rating

Diazocine derivatives and their use as tryptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diazocine derivatives and their use as tryptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazocine derivatives and their use as tryptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3498807